Advancing and developing first-in-class GIP antagonists for obesity and related conditions
Helicore Biopharma is a dynamic biopharmaceutical company focused on developing innovative therapeutics for obesity and related metabolic conditions. Located at 1825 South Grant Street, San Mateo, CA 94402, US, Helicore Biopharma is dedicated to advancing a portfolio of next-generation treatments with a novel approach to glucose-dependent insulinotropic peptide (GIP) antagonism.
Helicore Biopharma leverages a proprietary platform of monoclonal antibodies designed to improve the efficacy, dosing, and tolerability of anti-obesity therapies. Helicore Biopharma is committed to delivering superior treatment outcomes through enhanced efficacy, tolerability, and convenient dosing regimens.
With a focus on addressing critical unmet needs in the field, Helicore Biopharma is rapidly advancing its differentiated portfolio. We invite the manager of Helicore Biopharma to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility and commercial development.
Helicore Biopharma est une société biopharmaceutique dynamique axée sur le développement de traitements innovants pour l'obésité et les affections métaboliques connexes. Située au 1825 South Grant Street, San Mateo, CA 94402, US, Helicore Biopharma se consacre à l'avancement d'un portefeuille de traitements de nouvelle génération avec une approche novatrice de l'antagonisme du peptide insulinotrope dépendant du glucose (GIP).
Helicore Biopharma exploite une plateforme exclusive d'anticorps monoclonaux conçue pour améliorer l'efficacité, la posologie et la tolérabilité des thérapies anti-obésité. Helicore Biopharma s'engage à fournir des résultats de traitement supérieurs grâce à une efficacité, une tolérabilité et des schémas posologiques pratiques améliorés.
En mettant l'accent sur la réponse aux besoins non satisfaits critiques dans le domaine, Helicore Biopharma fait progresser rapidement son portefeuille différencié. Nous invitons le directeur d'Helicore Biopharma à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore sa visibilité et son développement commercial.
Compare Helicore Biopharma with 3 companies in Biotechnology-Research
| Comparison Field |
Helicore BiopharmaMain Company |
RoukenBioView Profile |
UAE BioTech Symposiu...View Profile |
HealumView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2015 | ||
|
Company Size
|
— | 51-200 | 2-10 | 2-10 |
|
City
|
San Mateo, CA | Motherwell, Scotland | ||
|
Country
|
United States | |||
|
Skills & Keywords
Comparing with main company
|
27 Total Skills
Biopharmaceutical
Obesity Treatment
GIP Antagonism
Metabolic Conditions
Monoclonal Antibodies
Drug Discovery
Weight-Loss Therapies
type 2 diabetes
incretin hormones
GIP neutralization
GIP antagonism
GIP
drug discovery
cardiometabolic
GIP conjugate
GLP-1
biopharmaceutical
gut peptides
glucose-dependent insulinotropic polypeptide
obesity
HCR-188
anti-obesity
GIP ligbinding
GIP antagonist
leptin resistance
weight-loss therapies
biologics
|
27 Total
27 Unique
Unique Skills:
ADCC
ADCs
antibodytherapeutics
Bioassays
Biosimilars
Bi-specifics
+21
|
15 Total
15 Unique
Unique Skills:
abudhabi
biopharma
biotechnology
cell therapy
clinical trials
GCC
+9
|
7 Total
7 Unique
Unique Skills:
behaviour science
cardiovascular disease
data science
digital health
mhealth
remote management
+1
|
Other organizations in the same industry
This company is also known as